These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 17548520)

  • 41. Ubiquitin-mediated activation of TAK1 and IKK.
    Adhikari A; Xu M; Chen ZJ
    Oncogene; 2007 May; 26(22):3214-26. PubMed ID: 17496917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphorylation of heat shock protein 27 antagonizes TNF-α induced HeLa cell apoptosis via regulating TAK1 ubiquitination and activation of p38 and ERK signaling.
    Qi Z; Shen L; Zhou H; Jiang Y; Lan L; Luo L; Yin Z
    Cell Signal; 2014 Jul; 26(7):1616-25. PubMed ID: 24686082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of natural killer T-cell development by deubiquitinase CYLD.
    Lee AJ; Zhou X; Chang M; Hunzeker J; Bonneau RH; Zhou D; Sun SC
    EMBO J; 2010 May; 29(9):1600-12. PubMed ID: 20224552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of alpha-AR subtypes in T lymphocytes and role of the alpha-ARs in mediating modulation of T cell function.
    Bao JY; Huang Y; Wang F; Peng YP; Qiu YH
    Neuroimmunomodulation; 2007; 14(6):344-53. PubMed ID: 18463421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transforming growth factor β-activated kinase 1 negatively regulates interleukin-1α-induced stromal-derived factor-1 expression in vascular smooth muscle cells.
    Yang B; Li W; Zheng Q; Qin T; Wang K; Li J; Guo B; Yu Q; Wu Y; Gao Y; Cheng X; Hu S; Kumar SN; Liu S; Song Z
    Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):130-6. PubMed ID: 26002466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survival and maintenance of regulatory T cells require the kinase TAK1.
    Chang JH; Hu H; Sun SC
    Cell Mol Immunol; 2015 Sep; 12(5):572-9. PubMed ID: 25891214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The tumour suppressor CYLD regulates the p53 DNA damage response.
    Fernández-Majada V; Welz PS; Ermolaeva MA; Schell M; Adam A; Dietlein F; Komander D; Büttner R; Thomas RK; Schumacher B; Pasparakis M
    Nat Commun; 2016 Aug; 7():12508. PubMed ID: 27561390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Truncation of the catalytic domain of the cylindromatosis tumor suppressor impairs lung maturation.
    Trompouki E; Tsagaratou A; Kosmidis SK; Dollé P; Qian J; Kontoyiannis DL; Cardoso WV; Mosialos G
    Neoplasia; 2009 May; 11(5):469-76. PubMed ID: 19412431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. It takes two to tango: a new couple in the family of ubiquitin-editing complexes.
    Wertz IE
    Nat Immunol; 2011 Nov; 12(12):1133-5. PubMed ID: 22089210
    [No Abstract]   [Full Text] [Related]  

  • 50. Truncation of the deubiquitinating domain of CYLD in myelomonocytic cells attenuates inflammatory responses.
    Tsagaratou A; Kontoyiannis DL; Mosialos G
    PLoS One; 2011 Jan; 6(1):e16397. PubMed ID: 21283724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Naturally occurring short splice variant of CYLD positively regulates dendritic cell function.
    Srokowski CC; Masri J; Hövelmeyer N; Krembel AK; Tertilt C; Strand D; Mahnke K; Massoumi R; Waisman A; Schild H
    Blood; 2009 Jun; 113(23):5891-5. PubMed ID: 19342479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Syndecan-4 negatively regulates antiviral signalling by mediating RIG-I deubiquitination via CYLD.
    Lin W; Zhang J; Lin H; Li Z; Sun X; Xin D; Yang M; Sun L; Li L; Wang H; Chen D; Sun Q
    Nat Commun; 2016 Jun; 7():11848. PubMed ID: 27279133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of CYLD Proteolysis by CASPASE 8 in Bone Marrow-Derived Macrophages.
    Legarda D; Ting AT
    Methods Mol Biol; 2018; 1857():181-188. PubMed ID: 30136242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD.
    Hövelmeyer N; Wunderlich FT; Massoumi R; Jakobsen CG; Song J; Wörns MA; Merkwirth C; Kovalenko A; Aumailley M; Strand D; Brüning JC; Galle PR; Wallach D; Fässler R; Waisman A
    J Exp Med; 2007 Oct; 204(11):2615-27. PubMed ID: 17923499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutual regulation between deubiquitinase CYLD and retroviral oncoprotein Tax.
    Wu X; Zhang M; Sun SC
    Cell Biosci; 2011 Aug; 1():27. PubMed ID: 21824392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ubiquitin ligases in T cell activation and autoimmunity.
    Zhang J
    Clin Immunol; 2004 Jun; 111(3):234-40. PubMed ID: 15183144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable Outcome.
    Ridder DA; Urbansky LL; Witzel HR; Schindeldecker M; Weinmann A; Berndt K; Gerber TS; Köhler BC; Nichetti F; Ludt A; Gehrke N; Schattenberg JM; Heinrich S; Roth W; Straub BK
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer.
    Masoumi KC; Shaw-Hallgren G; Massoumi R
    J Skin Cancer; 2011; 2011():614097. PubMed ID: 22235375
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Natural killer T cell-a cat o' nine lives!
    Joyce S; Gordy LE
    EMBO J; 2010 May; 29(9):1475-6. PubMed ID: 20442728
    [No Abstract]   [Full Text] [Related]  

  • 60. A novel player in inflammation and cancer: the deubiquitinase CYLD controls HCC development.
    Gautheron J; Luedde T
    J Hepatol; 2012 Nov; 57(5):937-9. PubMed ID: 22878470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.